SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
出版年份 2021 全文链接
标题
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
作者
关键词
-
出版物
Science Immunology
Volume 6, Issue 59, Pages eabj1750
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-05-25
DOI
10.1126/sciimmunol.abj1750
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
- (2021) Antonin Bal et al. Eurosurveillance
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)
- (2021) Jeroen J. A. van Kampen et al. Nature Communications
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
- (2021) Xiaoying Shen et al. Cell Host & Microbe
- The great escape? SARS-CoV-2 variants evading neutralizing responses
- (2021) Jérémie Prévost et al. Cell Host & Microbe
- Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study
- (2021) Gerco den Hartog et al. CLINICAL INFECTIOUS DISEASES
- Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report
- (2021) Noémie Zucman et al. CLINICAL INFECTIOUS DISEASES
- Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19
- (2021) Ji Yun Noh et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- COVID-19 vaccination: the VOICE for patients with cancer
- (2021) Astrid A. M. van der Veldt et al. NATURE MEDICINE
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma
- (2021) For Yue Tso et al. PLoS One
- A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
- (2021) Thomas Hale et al. Nature Human Behaviour
- SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses
- (2021) Benedikt Agerer et al. Science Immunology
- Prolonged evolution of the human B cell response to SARS-CoV-2 infection
- (2021) Mrunal Sakharkar et al. Science Immunology
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
- (2021) Venkata Viswanadh Edara et al. Cell Host & Microbe
- SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
- (2021) Irene Cassaniti et al. CLINICAL MICROBIOLOGY AND INFECTION
- Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection
- (2021) Chang Kyung Kang et al. JOURNAL OF INFECTIOUS DISEASES
- Correlates of protection from SARS-CoV-2 infection
- (2021) Florian Krammer LANCET
- Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
- (2021) Salim S Abdool Karim LANCET
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
- (2021) Ane Ogbe et al. Nature Communications
- SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
- (2021) Andrew G Letizia et al. Lancet Respiratory Medicine
- CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
- (2021) Andrew D Redd et al. Open Forum Infectious Diseases
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence
- (2020) Gerco den Hartog et al. JOURNAL OF INFECTIOUS DISEASES
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
- (2020) Camille Maringe et al. LANCET ONCOLOGY
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- A single-cell atlas of the peripheral immune response in patients with severe COVID-19
- (2020) Aaron J. Wilk et al. NATURE MEDICINE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
- (2020) Corine H. GeurtsvanKessel et al. Nature Communications
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
- (2020) Daniela Weiskopf et al. Science Immunology
- Genomic evidence for reinfection with SARS-CoV-2: a case study
- (2020) Richard L Tillett et al. LANCET INFECTIOUS DISEASES
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
- (2020) David Schub et al. JCI Insight
- Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019
- (2020) Jee-Soo Lee et al. CLINICAL INFECTIOUS DISEASES
- The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
- (2020) Ahmed Babiker et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
- (2020) Alicia T. Widge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
- (2020) Mads Delbo Larsen et al. SCIENCE
- Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk–Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity
- (2017) Rory D de Vries et al. JOURNAL OF INFECTIOUS DISEASES
- Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection
- (2017) Rory D. de Vries et al. VACCINE
- Pre-fusion structure of a human coronavirus spike protein
- (2016) Robert N. Kirchdoerfer et al. NATURE
- Age-Associated Cross-reactive Antibody-Dependent Cellular Cytotoxicity Toward 2009 Pandemic Influenza A Virus Subtype H1N1
- (2013) Sinthujan Jegaskanda et al. JOURNAL OF INFECTIOUS DISEASES
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started